Connect Biopharma Holdings Limited (CNTB) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 156.96M |
| Enterprise Value | 119.31M |
| P/E Ratio | -2.32 |
| PEG Ratio | 0.03 |
| Price/Sales Ratio | 43.73 |
| Price/Book Ratio | 4.78 |
| Enterprise/Revenue | 34.74 |
| Enterprise/EBITDA | -1.97 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -17.63 |
| Operating Margin | -17.96 |
AD
Management Effectiveness
| Return On Assets | -1.19 |
| Return On Equity | -1.5 |
Income Statement
| Revenue | 64,000 |
| Revenue/Share | 0.05 |
| Gross Profit | 64,000 |
| EBITDA | -54.58M |
| Net Income | -55.48M |
| Diluted EPS | -1 |
Balance Sheet
| Total Cash | 31.49M |
| Total Cash/Share | 0.5 |
| Total Debt | 596,000 |
| Total Debt/Equity | 0.02 |
| Current Ratio | 2.37 |
| Book Value Per Share | 0.43 |
Price History
| 52-Week Change | 30.77 |
| 52-Week High | 3.82 |
| 52-Week Low | 1.23 |
| Moving Average 50 Days | 2.25 |
| Moving Average 200 Days | 2.45 |
Statistics
| Average Volume | 666,453 |
| Shares Outstanding | 62.96M |
| % Held by Institutions | 22.12 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
